Publications
Journal Articles
Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer
Published in NPJ Breast Cancer, 2024
Use Google Scholar for full citation
Recommended citation: Reid Powell, "Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer." NPJ Breast Cancer, 2024.
Small-Molecule-Screening-Identifies-HSP90-as-a-Modifier-of-RNA-Foci-in-Myotonic-Dystrophy-Type-1
Published in Molecular and Cellular Biology, 2024
Use Google Scholar for full citation
Recommended citation: Sara Johnson, Hannah Johnson, Reid Powell, Clifford Stephan, Fabio Stossi, Thomas Cooper. "Small-Molecule-Screening-Identifies-HSP90-as-a-Modifier-of-RNA-Foci-in-Myotonic-Dystrophy-Type-1." Molecular and Cellular Biology, 2024.
PDX models of TNBC established from pre-and post-therapy tumors identify vulnerabilities of resistant disease
Published in Cancer Research, 2024
Use Google Scholar for full citation
Recommended citation: Amanda Rinkenbaugh, "PDX models of TNBC established from pre-and post-therapy tumors identify vulnerabilities of resistant disease." Cancer Research, 2024.
EphA2 and HDAC-Targeted Combination Therapy in Endometrial Cancer
Published in International journal of molecular sciences, 2024
Use Google Scholar for full citation
Recommended citation: Robiya Joseph, "EphA2 and HDAC-Targeted Combination Therapy in Endometrial Cancer." International journal of molecular sciences, 2024.
Enhancing-efficacy-of-the-MEK-inhibitor-trametinib-with-paclitaxel-in-KRAS-mutated-colorectal-cancer
Published in bioRxiv, 2024
Use Google Scholar for full citation
Recommended citation: Susmita Ghosh, Fan Fan, Reid Powell, Yong Park, Clifford Stephan, Scott Kopetz, Lee Ellis, Rajat Bhattacharya. "Enhancing-efficacy-of-the-MEK-inhibitor-trametinib-with-paclitaxel-in-KRAS-mutated-colorectal-cancer." bioRxiv, 2024.
Cystic-fibrosis-cell-models-for-high-throughput-analysis-and-drug-screening
Published in Journal of Cystic Fibrosis, 2024
Use Google Scholar for full citation
Recommended citation: Aidi Liu, Mithil Chokshi, Nghi Nguyen, Reid Powell, Clifford Stephan, Gang Bao. "Cystic-fibrosis-cell-models-for-high-throughput-analysis-and-drug-screening." Journal of Cystic Fibrosis, 2024.
Chemical-genetic-analysis-of-enoxolone-inhibition-of-C.-difficile-toxin-production-reveals-adenine-deaminase-and-ATP-synthase-as-anti-virulence-targets
Published in Journal of Biological Chemistry, 2024
Use Google Scholar for full citation
Recommended citation: Ravi Marreddy, Gregory Phelps, Kelly Churion, Jonathan Picker, Reid Powell, Philip Cherian, John Bowling, Clifford Stephan, Richard Lee, Julian Hurdle. "Chemical-genetic-analysis-of-enoxolone-inhibition-of-C.-difficile-toxin-production-reveals-adenine-deaminase-and-ATP-synthase-as-anti-virulence-targets." Journal of Biological Chemistry, 2024.
Vincristine enhances the efficacy of MEK inhibitors in preclinical models of KRAS-mutant colorectal cancer
Published in Molecular cancer therapeutics, 2023
Use Google Scholar for full citation
Recommended citation: Susmita Ghosh, "Vincristine enhances the efficacy of MEK inhibitors in preclinical models of KRAS-mutant colorectal cancer." Molecular cancer therapeutics, 2023.
The-Effects-of-Transplantation-of-the-Spaceflight-Intestinal-Microbiome-on-Short-Chain-Fatty-Acid-Production,-Lymphoid-organ-Immune-Composition-and-Transport-Kinetics
Published in Unknown Venue, 2023
Use Google Scholar for full citation
Recommended citation: Reid Powell, Mark Endsley, Walter Cromer. "The-Effects-of-Transplantation-of-the-Spaceflight-Intestinal-Microbiome-on-Short-Chain-Fatty-Acid-Production,-Lymphoid-organ-Immune-Composition-and-Transport-Kinetics." Unknown Venue, 2023.
Targeting-FOXL2C402G-vulnerabilities-in-adult-type-ovarian-granulosa-cell-tumors
Published in Cancer Research, 2023
Use Google Scholar for full citation
Recommended citation: Thomas Welte, Veena Vuttaradhi, Eleonora Khlebus, Barrett Lawson, Robert Hillman, Nghi Nguyen, Mary Sobieski, Reid Powell, Clifford Stephan. "Targeting-FOXL2C402G-vulnerabilities-in-adult-type-ovarian-granulosa-cell-tumors." Cancer Research, 2023.
Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state
Published in British journal of cancer, 2023
Use Google Scholar for full citation
Recommended citation: Wangie Yu, "Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state." British journal of cancer, 2023.
Crizotinib-enhances-the-efficacy-of-BX-795-identified-by-high-throughput-screening-of-pan-active-drugs-in-colorectal-cancer-cells
Published in Cancer Research, 2023
Use Google Scholar for full citation
Recommended citation: Susmita Ghosh, Fan Fan, Jason Roszik, Reid Powell, Yong Park, Clifford Stephan, Lee Ellis, Rajat Bhattacharya. "Crizotinib-enhances-the-efficacy-of-BX-795-identified-by-high-throughput-screening-of-pan-active-drugs-in-colorectal-cancer-cells." Cancer Research, 2023.
Concurrent-inactivation-of-PI3K-and-PLK1-is-synergistic-and-overcomes-acquired-resistance-to-PI3K-inhibitors-in-NOTCH1-MUT-HNSCC
Published in Cancer Research, 2023
Use Google Scholar for full citation
Recommended citation: Pooja Shah, Tuhina Mazumdar, Reid Powell, Li Shen, Jing Wang, Clifford Stephen, Mitchell Frederick, Faye Johnson. "Concurrent-inactivation-of-PI3K-and-PLK1-is-synergistic-and-overcomes-acquired-resistance-to-PI3K-inhibitors-in-NOTCH1-MUT-HNSCC." Cancer Research, 2023.
Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo
Published in Plos one, 2023
Use Google Scholar for full citation
Recommended citation: Fan Fan, "Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo." Plos one, 2023.
Combination of EphA2-and Wee1-targeted therapies in Endometrial Cancer
Published in International journal of molecular sciences, 2023
Use Google Scholar for full citation
Recommended citation: Santosh Dasari, "Combination of EphA2-and Wee1-targeted therapies in Endometrial Cancer." International journal of molecular sciences, 2023.
Abstract P6-10-19: Screening of GPCR-targeting drugs for repositioning in breast cancer
Published in In the proceedings of Cancer Research, 2023
Use Google Scholar for full citation
Recommended citation: Noor Abdulkareem, "Abstract P6-10-19: Screening of GPCR-targeting drugs for repositioning in breast cancer." In the proceedings of Cancer Research, 2023.
Abstract P3060: Modeling Immune Checkpoint Inhibitor Associated Myocarditis In Vitro
Published in In the proceedings of Circulation Research, 2023
Use Google Scholar for full citation
Recommended citation: Garrett Jensen, "Abstract P3060: Modeling Immune Checkpoint Inhibitor Associated Myocarditis In Vitro." In the proceedings of Circulation Research, 2023.
Abstract-B171:-BX-795-enhances-the-efficacy-of-crizotinib-in-colorectal-cancer-cells-by-altering-the-activity-of-aurora-kinases
Published in In the proceedings of Molecular Cancer Therapeutics, 2023
Use Google Scholar for full citation
Recommended citation: Susmita Ghosh, Fan Fan, Reid Powell, Yong Park, Clifford Stephan, Jason Roszik, Lee Ellis, Rajat Bhattacharya. "Abstract-B171:-BX-795-enhances-the-efficacy-of-crizotinib-in-colorectal-cancer-cells-by-altering-the-activity-of-aurora-kinases." In the proceedings of Molecular Cancer Therapeutics, 2023.
A Novel Transgenic Mouse Model of Down Syndrome Acute Lymphoblastic Leukemia Identifies Targetable Vulnerabilities
Published in Blood, 2023
Use Google Scholar for full citation
Recommended citation: Jacob Junco, "A Novel Transgenic Mouse Model of Down Syndrome Acute Lymphoblastic Leukemia Identifies Targetable Vulnerabilities." Blood, 2023.
35P-Enhancing-efficacy-of-the-MEK-inhibitor-trametinib-in-KRAS-mutated-colorectal-cancer-cells
Published in ESMO Open, 2023
Use Google Scholar for full citation
Recommended citation: LM Ellis, S Ghosh, F Fan, R Bhattacharya, R Powell, YS Park, C Stephan. "35P-Enhancing-efficacy-of-the-MEK-inhibitor-trametinib-in-KRAS-mutated-colorectal-cancer-cells." ESMO Open, 2023.
deepOrganoid:-A-brightfield-cell-viability-model-for-screening-matrix-embedded-organoids
Published in SLAS Discovery, 2022
Recommended citation: Reid Powell, Micheline Moussalli, Lei Guo, Goeun Bae, Pankaj Singh, Clifford Stephan, Imad Shureiqi, Peter Davies. "deepOrganoid:-A-brightfield-cell-viability-model-for-screening-matrix-embedded-organoids." SLAS Discovery, 2022.
Download Paper
Combined-inhibition-of-HMGCoA-reductase-and-mitochondrial-complex-I-induces-tumor-regression-of-BRAF-inhibitor-resistant-melanomas
Published in Cancer & Metabolism, 2022
Recommended citation: Evelyn Groot, Sruthy Varghese, Lin Tan, Barbara Knighton, Mary Sobieski, Nghi Nguyen, Yong Park, Reid Powell, Philip Lorenzi, Bin Zheng, Clifford Stephan, Y. Gopal. "Combined-inhibition-of-HMGCoA-reductase-and-mitochondrial-complex-I-induces-tumor-regression-of-BRAF-inhibitor-resistant-melanomas." Cancer & Metabolism, 2022.
Download Paper
The-licorice-metabolite-enoxolone-attenuates-Clostridioides-difficile-pathophysiology-by-corrupting-its-metabolic-and-toxin-production-networks
Published in bioRxiv, 2022
Use Google Scholar for full citation
Recommended citation: Ravi Marreddy, Jonathan Picker, Gregory Phelps, Reid Powell, Philip Cherian, John Bowling, Clifford Stephan, Richard Lee, Julian Hurdle. "The-licorice-metabolite-enoxolone-attenuates-Clostridioides-difficile-pathophysiology-by-corrupting-its-metabolic-and-toxin-production-networks." bioRxiv, 2022.
Screening of GPCR drugs for repurposing in breast cancer
Published in Frontiers in Pharmacology, 2022
Use Google Scholar for full citation
Recommended citation: Noor Abdulkareem, "Screening of GPCR drugs for repurposing in breast cancer." Frontiers in Pharmacology, 2022.
Rb-deficient-HPV+-HNSCC-experienced-enhanced-sensitivity-to-aurora-kinase-inhibitors-by-altering-the-balance-of-MAD2-and-TRIP13-levels
Published in Cancer Research, 2022
Use Google Scholar for full citation
Recommended citation: Soma Ghosh, Tuhina Mazumdar, Wei Xu, Reid Powell, Clifford Stephan, Li Shen, Curtis Pickering, Jing Wang, Faye Johnson. "Rb-deficient-HPV+-HNSCC-experienced-enhanced-sensitivity-to-aurora-kinase-inhibitors-by-altering-the-balance-of-MAD2-and-TRIP13-levels." Cancer Research, 2022.
Molecular-pathways-enhance-drug-response-prediction-using-transfer-learning-from-cell-lines-to-tumors-and-patient-derived-xenografts
Published in Scientific Reports, 2022
Use Google Scholar for full citation
Recommended citation: Yi-Ching Tang, Reid Powell, Assaf Gottlieb. "Molecular-pathways-enhance-drug-response-prediction-using-transfer-learning-from-cell-lines-to-tumors-and-patient-derived-xenografts." Scientific Reports, 2022.
Determining-efficacy-of-combining-the-MEK-inhibitor-trametinib-with-vincristine-identified-by-unbiased-high-throughput-screening-in-RAS-mutated-colorectal-cancer-cells
Published in Cancer Research, 2022
Use Google Scholar for full citation
Recommended citation: Susmita Ghosh, Fan Fan, Jason Roszik, Reid Powell, Yong Park, Clifford Stephan, Lee Ellis, Rajat Bhattacharya. "Determining-efficacy-of-combining-the-MEK-inhibitor-trametinib-with-vincristine-identified-by-unbiased-high-throughput-screening-in-RAS-mutated-colorectal-cancer-cells." Cancer Research, 2022.
Chemically targeting the redox switch in AP1 transcription factor $Delta$FOSB
Published in Nucleic acids research, 2022
Use Google Scholar for full citation
Recommended citation: Ashwani Kumar, "Chemically targeting the redox switch in AP1 transcription factor $Delta$FOSB." Nucleic acids research, 2022.
Abstract GS1-09: Inhibition of GPX4 induces preferential death of p53-mutant triple-negative breast cancer cells
Published in In the proceedings of Cancer Research, 2022
Use Google Scholar for full citation
Recommended citation: William Tahaney, "Abstract GS1-09: Inhibition of GPX4 induces preferential death of p53-mutant triple-negative breast cancer cells." In the proceedings of Cancer Research, 2022.
Endocrine-disrupting-chemicals-differentially-alter-intranuclear-dynamics-and-transcriptional-activation-of-estrogen-receptor-$upalpha$
Published in iScience, 2021
Recommended citation: Michael Bolt, Pankaj Singh, Caroline Obkirchner, Reid Powell, Maureen Mancini, Adam Szafran, Fabio Stossi, Michael Mancini. "Endocrine-disrupting-chemicals-differentially-alter-intranuclear-dynamics-and-transcriptional-activation-of-estrogen-receptor-$upalpha$." iScience, 2021.
Download Paper
Rational-Combination-of-CRM1-Inhibitor-Selinexor-and-Olaparib-Shows-Synergy-in-Ovarian-Cancer-Cell-Lines-and-Mouse-Models
Published in Molecular Cancer Therapeutics, 2021
Recommended citation: Katelyn Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, Elaine Stur, Robiya Joseph, Emine Bayraktar, Santosh Dasari, Nghi Nguyen, Reid Powell, Mary Sobieski, Cristina Ivan, Mark Kim, Sujanitha Umamaheswaran, Deanna Glassman, Yunfei Wen, Paola Amero, Clifford Stephan, Robert Coleman, Yosef Landesman, Shannon Westin, Prahlad Ram, Anil Sood. "Rational-Combination-of-CRM1-Inhibitor-Selinexor-and-Olaparib-Shows-Synergy-in-Ovarian-Cancer-Cell-Lines-and-Mouse-Models." Molecular Cancer Therapeutics, 2021.
Download Paper
Mammary-specific-expression-of-Trim24-establishes-a-mouse-model-of-human-metaplastic-breast-cancer
Published in Nature Communications, 2021
Recommended citation: Vrutant Shah, Aundrietta Duncan, Shiming Jiang, Sabrina Stratton, Kendra Allton, Clinton Yam, Abhinav Jain, Patrick Krause, Yue Lu, Shirong Cai, Yizheng Tu, Xinhui Zhou, Xiaomei Zhang, Yan Jiang, Christopher Carroll, Zhijun Kang, Bin Liu, Jianjun Shen, Mihai Gagea, Sebastian Manu, Lei Huo, Michael Gilcrease, Reid Powell, Lei Guo, Clifford Stephan, Peter Davies, Jan Parker-Thornburg, Guillermina Lozano, Richard Behringer, Helen Piwnica-Worms, Jeffrey Chang, Stacy Moulder, Michelle Barton. "Mammary-specific-expression-of-Trim24-establishes-a-mouse-model-of-human-metaplastic-breast-cancer." Nature Communications, 2021.
Download Paper
Morphological-screening-of-mesenchymal-mammary-tumor-organoids-to-identify-drugs-that-reverse-epithelial-mesenchymal-transition
Published in Nature Communications, 2021
Recommended citation: Na Zhao, Reid Powell, Xueying Yuan, Goeun Bae, Kevin Roarty, Fabio Stossi, Martina Strempfl, Michael Toneff, Hannah Johnson, Sendurai Mani, Philip Jones, Clifford Stephan, Jeffrey Rosen. "Morphological-screening-of-mesenchymal-mammary-tumor-organoids-to-identify-drugs-that-reverse-epithelial-mesenchymal-transition." Nature Communications, 2021.
Download Paper
A-High-Throughput-Approach-to-Identify-Effective-Systemic-Agents-for-the-Treatment-of-Anaplastic-Thyroid-Carcinoma
Published in The Journal of Clinical Endocrinology & Metabolism, 2021
Recommended citation: Ying Henderson, Abdallah Mohamed, Anastasios Maniakas, Yunyun Chen, Reid Powell, Shaohua Peng, Maria Cardenas, Michelle Williams, Diana Bell, Mark Zafereo, Rui Wang, Steve Scherer, David Wheeler, Maria Cabanillas, Marie-Claude Hofmann, Faye Johnson, Clifford Stephan, Vlad Sandulache, Stephen Lai. "A-High-Throughput-Approach-to-Identify-Effective-Systemic-Agents-for-the-Treatment-of-Anaplastic-Thyroid-Carcinoma." The Journal of Clinical Endocrinology & Metabolism, 2021.
Download Paper
Therapeutically-actionable-signaling-node-to-rescue-AURKA-driven-loss-of-primary-cilia-in-VHL-deficient-cells
Published in Scientific Reports, 2021
Recommended citation: Pratim Chowdhury, Dimuthu Perera, Reid Powell, Tia Talley, Durga Tripathi, Yong Park, Michael Mancini, Peter Davies, Clifford Stephan, Cristian Corfa, Ruhee Dere. "Therapeutically-actionable-signaling-node-to-rescue-AURKA-driven-loss-of-primary-cilia-in-VHL-deficient-cells." Scientific Reports, 2021.
Download Paper
Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells
Published in Scientific Reports, 2021
Use Google Scholar for full citation
Recommended citation: Pratim Chowdhury, "Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells." Scientific Reports, 2021.
Targeting the Oncogenic Functions of an RNA-Binding Protein Involved in Hematologic Malignancies
Published in Blood, 2021
Use Google Scholar for full citation
Recommended citation: Sean Post, "Targeting the Oncogenic Functions of an RNA-Binding Protein Involved in Hematologic Malignancies." Blood, 2021.
Identification-of-pathways-that-enhance-cell-death-in-NOTCH1-mutant-HNSCC
Published in Cancer Research, 2021
Use Google Scholar for full citation
Recommended citation: Pooja Shah, Tuhina Mazumdar, Reid Powell, Li Shen, Jing Wang, Clifford Stephen, Mitchell Frederick, Faye Johnson. "Identification-of-pathways-that-enhance-cell-death-in-NOTCH1-mutant-HNSCC." Cancer Research, 2021.
Endocrine-disrupting-chemicals-differentially-alter-intranuclear-dynamics-and-transcriptional-activation-of-estrogen-receptor-$alpha$
Published in Iscience, 2021
Use Google Scholar for full citation
Recommended citation: Michael Bolt, Pankaj Singh, Caroline Obkirchner, Reid Powell, Maureen Mancini, Adam Szafran, Fabio Stossi, Michael Mancini. "Endocrine-disrupting-chemicals-differentially-alter-intranuclear-dynamics-and-transcriptional-activation-of-estrogen-receptor-$alpha$." Iscience, 2021.
Author Correction: Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells
Published in Scientific Reports, 2021
Use Google Scholar for full citation
Recommended citation: Pratim Chowdhury, "Author Correction: Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells." Scientific Reports, 2021.
Aurora-kinase-inhibitors-cause-cell-death-in-HPV+-cells:-A-plausible-treatment-option-for-HPV+-cancers
Published in Cancer Research, 2021
Use Google Scholar for full citation
Recommended citation: Tuhina Mazumdar, Li Shen, Wei Xu, Soma Ghosh, Reid Powell, Clifford Stephan, Curtis Pickering, Jeffery Myers, Jing Wang, Faye Johnson. "Aurora-kinase-inhibitors-cause-cell-death-in-HPV+-cells:-A-plausible-treatment-option-for-HPV+-cancers." Cancer Research, 2021.
Unbiased-high-throughput-screenings-to-identify-combination-therapies-targeting-RAS-mutated-colorectal-cancer.
Published in Unknown Venue, 2020
Use Google Scholar for full citation
Recommended citation: Reid Powell, Fan Fan, Mary Sobieski, David Brunell, Rui Wang, Xiangcang Ye, Clifford Stephan, Lee Ellis, Rajat Bhattacharya. "Unbiased-high-throughput-screenings-to-identify-combination-therapies-targeting-RAS-mutated-colorectal-cancer.." Unknown Venue, 2020.
Pharmacologic-profiling-of-patient-derived-xenograft-models-of-primary-treatment-na"ive-triple-negative-breast-cancer
Published in Unknown Venue, 2020
{Abstract Triple-negative breast cancer (TNBC) accounts for 15{\textendash}20\% of breast cancer cases in the United States, lacks targeted therapeutic options, and is associated with a 40{\textendash}80\% risk of recurrence. Thus, identifying actionable targets in treatment-na{\"\i}ve and chemoresistant TNBC is a critical unmet medical need. To address this need, we performed high-throughput drug viability screens on human tumor cells isolated from 16 patient-derived xenograft models of treatment-na{\"\i}ve primary TNBC. The models span a range of TNBC subtypes and exhibit a diverse set of putative driver mutations, thus providing a unique patient-derived, molecularly annotated pharmacologic resource that is reflective of TNBC. We identified therapeutically actionable targets including kinesin spindle protein (KSP). The KSP inhibitor targets the mitotic spindle through mechanisms independent of microtubule stability and showed efficacy in models that were resistant to microtubule inhibitors used as part of the current standard of care for TNBC. We also observed subtype selectivity of Prima-1Met, which showed higher levels of efficacy in the mesenchymal subtype. Coupling pharmacologic data with genomic and transcriptomic information, we showed that Prima-1Met activity was independent of its canonical target, mutant p53, and was better associated with glutathione metabolism, providing an alternate molecularly defined biomarker for this drug.}
Recommended citation: Reid Powell, Abena Redwood, Xuan Liu, Lei Guo, Shirong Cai, Xinhui Zhou, Yizheng Tu, Xiaomei Zhang, Yuan Qi, Yan Jiang, Gloria Echeverria, Ningping Feng, XiaoYan Ma, Virginia Giuliani, Joseph Marszalek, Timothy Heffernan, Christopher Vellano, Jason White, Clifford Stephan, Peter Davies, Stacy Moulder, W. Symmans, Jeffrey Chang, Helen Piwnica-Worms. "Pharmacologic-profiling-of-patient-derived-xenograft-models-of-primary-treatment-na"ive-triple-negative-breast-cancer." Unknown Venue, 2020.
Download Paper
High throughput chemical profiling of chemoresistant triple negative breast cancer
Published in Cancer Research, 2020
Use Google Scholar for full citation
Recommended citation: Reid Powell, "High throughput chemical profiling of chemoresistant triple negative breast cancer." Cancer Research, 2020.
Determining-efficacy-of-drug-combinations-identified-by-unbiased-high-throughput-screening-for-RAS-mutated-colorectal-cancer
Published in Cancer Research, 2020
Use Google Scholar for full citation
Recommended citation: Fan Fan, Reid Powell, Jason Roszik, Rui Wang, Xiangcang Ye, Clifford Stephan, Lee Ellis, Rajat Bhattacharya. "Determining-efficacy-of-drug-combinations-identified-by-unbiased-high-throughput-screening-for-RAS-mutated-colorectal-cancer." Cancer Research, 2020.
Abstract-P3-03-08:-Identification-of-drugs-that-induce-the-death-or-suppress-the-growth-of-p53-mutant-breast-cancer
Published in In the proceedings of Cancer Research, 2020
Use Google Scholar for full citation
Recommended citation: William Tahaney, Reid Powell, Nghi Nguyen, Lakshmi Bollu, Jing Qian, Abhijit Mazumdar, Clifford Stephan, Peter Davies, Powel Brown. "Abstract-P3-03-08:-Identification-of-drugs-that-induce-the-death-or-suppress-the-growth-of-p53-mutant-breast-cancer." In the proceedings of Cancer Research, 2020.
Abstract-B20:-Unbiased-high-throughput-screenings-to-identify-combination-therapies-targeting-RAS-mutated-colorectal-cancer
Published in In the proceedings of Molecular Cancer Research, 2020
Use Google Scholar for full citation
Recommended citation: Reid Powell, Fan Fan, Mary Sobieski, David Brunell, Rui Wang, Xiangcang Ye, Clifford Stephan, Lee Ellis, Rajat Bhattacharya. "Abstract-B20:-Unbiased-high-throughput-screenings-to-identify-combination-therapies-targeting-RAS-mutated-colorectal-cancer." In the proceedings of Molecular Cancer Research, 2020.
Single cell transcriptomic profiling of ex vivo tumoroid models reveal therapeutic vulnerabilities of pancreatic ductal adenocarcinoma
Published in Cancer Research, 2019
Use Google Scholar for full citation
Recommended citation: Vincent Bernard, "Single cell transcriptomic profiling of ex vivo tumoroid models reveal therapeutic vulnerabilities of pancreatic ductal adenocarcinoma." Cancer Research, 2019.
High-throughput-screening-against-protein:protein-interaction-interfaces-reveals-anti-cancer-therapeutics-as-potent-modulators-of-the-voltage-gated-Na+-channel-complex
Published in Unknown Venue, 2019
{Abstract Multiple voltage-gated Na+ (Nav) channelopathies can be ascribed to subtle changes in the Nav macromolecular complex. Fibroblast growth factor 14 (FGF14) is a functionally relevant component of the Nav1.6 channel complex, a causative link to spinocerebellar ataxia 27 (SCA27) and an emerging risk factor for neuropsychiatric disorders. Yet, how this protein:channel complex is regulated in the cell is still poorly understood. To search for key cellular pathways upstream of the FGF14:Nav1.6 complex, we have developed, miniaturized and optimized an in-cell assay in 384-well plates by stably reconstituting the FGF14:Nav1.6 complex using the split-luciferase complementation assay. We then conducted a high-throughput screening (HTS) of 267 FDA-approved compounds targeting known mediators of cellular signaling. Of the 65 hits initially detected, 24 were excluded based on counter-screening and cellular toxicity. Based on target analysis, potency and dose-response relationships, 5 compounds were subsequently repurchased for validation and confirmed as hits. Among those, the tyrosine kinase inhibitor lestaurtinib was highest ranked, exhibiting submicromolar inhibition of FGF14:Nav1.6 assembly. While providing evidence for a robust in-cell HTS platform that can be adapted to search for any channelopathy-associated regulatory proteins, these results lay the potential groundwork for repurposing cancer drugs for neuropsychopharmacology.}
Recommended citation: Paul Wadsworth, Oluwarotimi Folorunso, Nghi Nguyen, Aditya Singh, Daniela D{\textquoteright}Amico, Reid Powell, David Brunell, John Allen, Clifford Stephan, Fernanda Laezza. "High-throughput-screening-against-protein:protein-interaction-interfaces-reveals-anti-cancer-therapeutics-as-potent-modulators-of-the-voltage-gated-Na+-channel-complex." Unknown Venue, 2019.
Download Paper
Bacteria-to-Human-Protein-Networks-Reveal-Origins-of-Endogenous-DNA-Damage
Published in Cell, 2019
Use Google Scholar for full citation
Recommended citation: J. Xia, L.-Y. Chiu, R.B. Nehring, M.A. Bravo, Q. Mei, M. Perez, Y. Zhai, D.M. Fitzgerald, J.P. Pribis, Y. Wang, C.W. Hu, R.T. Powell, S.A. LaBonte, A. Jalali, M.L. Matadamas, A.M. Lentzsch, A.T. Szafran, M.C. Joshi, M. Richters, J.L. Gibson, R.L. Frisch, P.J. Hastings, D. Bates, C. Queitsch, S.G. Hilsenbeck, C. Coarfa, J.C. Hu, D.A. Siegele, K.L. Scott, H. Liang, M.A. Mancini, C. Herman, K.M. Miller, S.M. Rosenberg. "Bacteria-to-Human-Protein-Networks-Reveal-Origins-of-Endogenous-DNA-Damage." Cell, 2019.
Extracting-Biological-Knowledge-from-High-Throughput-Phenotypic-Screens
Published in Unknown Venue, 2018
Use Google Scholar for full citation
Recommended citation: Reid Powell. "Extracting-Biological-Knowledge-from-High-Throughput-Phenotypic-Screens." Unknown Venue, 2018.
Bexarotene-?-A-novel-modulator-of-AURKA-and-the-primary-cilium-in-VHL-deficient-cells
Published in Journal of Cell Science, 2018
Use Google Scholar for full citation
Recommended citation: P. Chowdhury, R.T. Powell, C. Stephan, I.P. Uray, T. Talley, M. Karki, D.N. Tripathi, Y.S. Park, M.A. Mancini, P. Davies, R. Dere. "Bexarotene-?-A-novel-modulator-of-AURKA-and-the-primary-cilium-in-VHL-deficient-cells." Journal of Cell Science, 2018.
The role of hepatocyte nuclear factor 1 homeobox B (HNF1B) loss in chromophobe RCC (ChRCC) development
Published in Annals of Oncology, 2017
Use Google Scholar for full citation
Recommended citation: E Jonasch, "The role of hepatocyte nuclear factor 1 homeobox B (HNF1B) loss in chromophobe RCC (ChRCC) development." Annals of Oncology, 2017.
Radiogenomics-and-histomics-in-glioblastoma:-the-promise-of-linking-image-derived-phenotype-with-genomic-information
Published in Advances in Biology and Treatment of Glioblastoma, 2017
Use Google Scholar for full citation
Recommended citation: Michael Lehrer, Reid Powell, Souptik Barua, Donnie Kim, Shivali Narang, Arvind Rao. "Radiogenomics-and-histomics-in-glioblastoma:-the-promise-of-linking-image-derived-phenotype-with-genomic-information." Advances in Biology and Treatment of Glioblastoma, 2017.
HNF1B-loss-exacerbates-the-development-of-chromophobe-renal-cell-carcinomas
Published in Cancer Research, 2017
Use Google Scholar for full citation
Recommended citation: M. Sun, P. Tong, W. Kong, B. Dong, Y. Huang, I.Y. Park, L. Zhou, X.-D. Liu, Z. Ding, X. Zhang, S. Bai, P. German, R. Powell, Q. Wang, X. Tong, N.M. Tannir, S.F. Matin, W.K. Rathmell, G.N. Fuller, I.E. McCutcheon, C.L. Walker, J. Wang, E. Jonasch. "HNF1B-loss-exacerbates-the-development-of-chromophobe-renal-cell-carcinomas." Cancer Research, 2017.
Dual-Chromatin-and-Cytoskeletal-Remodeling-by-SETD2
Published in Cell, 2016
Use Google Scholar for full citation
Recommended citation: I.Y. Park, R.T. Powell, D.N. Tripathi, R. Dere, T.H. Ho, T.L. Blasius, Y.-C. Chiang, I.J. Davis, C.C. Fahey, K.E. Hacker, K.J. Verhey, M.T. Bedford, E. Jonasch, W.K. Rathmell, C.L. Walker. "Dual-Chromatin-and-Cytoskeletal-Remodeling-by-SETD2." Cell, 2016.
ATM-functions-at-the-peroxisome-to-induce-pexophagy-in-response-to-ROS
Published in Nature Cell Biology, 2015
Use Google Scholar for full citation
Recommended citation: J. Zhang, D.N. Tripathi, J. Jing, A. Alexander, J. Kim, R.T. Powell, R. Dere, J. Tait-Mulder, J.-H. Lee, T.T. Paull, R.K. Pandita, V.K. Charaka, T.K. Pandita, M.B. Kastan, C.L. Walker. "ATM-functions-at-the-peroxisome-to-induce-pexophagy-in-response-to-ROS." Nature Cell Biology, 2015.
Defining-estrogenic-mechanisms-of-bisphenol-A-analogs-through-high-throughput-microscopy-based-contextual-assays
Published in Chemistry and Biology, 2014
Use Google Scholar for full citation
Recommended citation: F. Stossi, M.J. Bolt, F.J. Ashcroft, J.E. Lamerdin, J.S. Melnick, R.T. Powell, R.D. Dandekar, M.G. Mancini, C.L. Walker, J.K. Westwick, M.A. Mancini. "Defining-estrogenic-mechanisms-of-bisphenol-A-analogs-through-high-throughput-microscopy-based-contextual-assays." Chemistry and Biology, 2014.